01 1Grindeks AS
01 1OXYTOCIN, USP
01 1Latvia
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-06-05
Pay. Date : 2012-11-23
DMF Number : 21777
Submission : 2008-06-27
Status : Active
Type : II
20
Joint Stock Co Grindeks, based in Latvia, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is OXYTOCIN, USP, with a corresponding US DMF Number 21777.
Remarkably, this DMF maintains an Active status since its submission on June 27, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 05, 2014, and payment made on November 23, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II
